Kidney Disease Clinical Trials

Showing 901-920 of 1,850 trials

Alternations of Intestinal Microbiota and Health Impact in CKD

NCT03794401

This study is aimed to evaluate the impact of dietary pattern, gut microbiota and their interactions on clinical outcomes among patient with CKD stage 3-5.

Chronic Kidney Disease

Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation750 participantsStarted Apr 2019

New Taipei City, Taiwan

COMPLETED

Appropriate Dosing to Optimise Personalised Cancer Treatments

NCT04154163

This is a pilot study to assess feasibility of dried blood spot (DBS) samples for pharmacokinetic measurements of targeted anti-cancer drugs in oncology patients such as patients with BRAF-mutant melanoma receiving targeted treatment with BRAF and MEK inhibitors.

Melanoma Stage IIIMelanoma Stage IVOvarian Cancer+3 more

University of Dundee18 participantsStarted Jan 2020

Dundee, Scotland, United Kingdom

COMPLETEDPHASE1

Pharmacokinetics of TD-4208 in Patients With Severe Renal Impairment

NCT02578082

This multiple-center, nonrandomized, open label, parallel group, single dose study will be conducted in male and female subjects with normal renal function or severe (eGFR \<30 mL/min/1.73 m2) renal impairment to evaluate the effect of renal impairment on the pharmacokinetics (PK) of TD 4208.

Renal Impairment

Mylan Inc.16 participantsStarted Dec 2015

Orlando, Florida, United States

COMPLETED

Kidney Affection in Non Alcaholic Fatty Liver Diseases

NCT04273230

Early detection of renal affection in patients with non alcaholic fatty liver diseases using microalbuminuria.

Renal Impairment

Assiut University114 participantsStarted Mar 2020

Asyut, Egypt • Asyut, Egypt

Alternations of Intestinal Microbiota and Health Impact in CKD

Appropriate Dosing to Optimise Personalised Cancer Treatments

Pharmacokinetics of TD-4208 in Patients With Severe Renal Impairment

Kidney Affection in Non Alcaholic Fatty Liver Diseases

Related Searches

Modified Preloaded System for Renal Arteries in Fenestrated Endografting (MPSRA)

Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer

"Retrospective Study to Identify Clinical Factors Related to a High Benefit of Axitinib in mRCC"

Cardiorenal Effecs of Losartan in Kidney Transplant Recipients

Endovascular Treatment of Thoracic Aortic Disease

Evaluation of Coffee Therapy for Improvement of Renal Oxygenation

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Association Between Stroke and Adrenal Incidentalomas

Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery

Safety Study of MGA271 in Refractory Cancer

Acute Kidney Injury in Patients With Sickle Cell Disease

Anlotinib Plus Sintilimab as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma

The Association Between Skeletal Muscle Mass and Severity of Polycystic Liver Disease and Polycystic Kidney Disease

Optimising Renal Outcome in Myeloma Renal Failure

Long Term Cardio-Vascular Risk Assessment in CKD and Kidney Transplanted Patients Following SARS-COV-2

Validation of a Sensor for Non-Invasive Measurements